ArticleLeukemia & lymphoma2023

AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas.

Pallawi Torka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.